Last checked at 22 Jul 2014 15:37
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades11,701
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,610.50
Bid:
1,607.50
Ask:
1,608.00
Change:
-33.00 (-2.01%)
Spread:
0.50 (0.031%)
Open:
1,626.50
High:
1,626.50
Low:
1,594.50
Prev. Close:
1,643.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.22 Jul 2014 15:14
22 Jul 2014 05:23
21 Jul 2014 23:00
Drugmakers to share neglected compounds with British academia
LONDON, July 22 (Reuters) - A group of seven leading drugmakers has agreed to share an array of neglected experimental medicines with British academic researchers in the latest example of the deepening ties between industry and external scientists. British business minister Vince Cable anno
Read more21 Jul 2014 17:28
21 Jul 2014 15:16
21 Jul 2014 05:29
18 Jul 2014 15:18
18 Jul 2014 12:54
Week ahead: ARM, Glaxo in focus amid a wave of blue-chip earnings
After a relatively quiet five sessions in terms of UK corporate earnings, things will pick up a gear next week with a host of blue chips expected to update the market on their recent performances. ARM Holdings, which designs chips used in smartphones and tablets, will be in focus on Tuesday as it r
Read more18 Jul 2014 12:23
Broker tips: GlaxoSmithKline, AstraZeneca, Housebuilders
Panmure Gordon said it is "not expecting fireworks" from GlaxoSmithKline's (GSK) second-quarter results due out next Wednesday. "In light of our recent downgrade to forecasts due to exchange rate headwinds, we are expecting another tough quarter. China has not washed through completely either and g
Read more18 Jul 2014 12:22
Panmure "not expecting fireworks" from Glaxo's Q2 results
Panmure Gordon is "not expecting fireworks" from GlaxoSmithKline's (GSK) second-quarter results due next Wednesday. "In light of our recent downgrade to forecasts due to exchange rate headwinds, we are expecting another tough quarter," said Analyst Savvas Neophytou. "China has not washed through c
Read more